Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Skinvisible (SKVI) Revenue (2016 - 2025)

Skinvisible (SKVI) has disclosed Revenue for 16 consecutive years, with $5000.0 as the latest value for Q4 2025.

  • Quarterly Revenue changed 0.0% to $5000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $20000.0 through Dec 2025, changed 0.0% year-over-year, with the annual reading at $20000.0 for FY2025, 0.0% changed from the prior year.
  • Revenue hit $5000.0 in Q4 2025 for Skinvisible, roughly flat from $5000.0 in the prior quarter.
  • In the past five years, Revenue ranged from a high of $287099.0 in Q2 2021 to a low of $5000.0 in Q4 2022.
  • Historically, Revenue has averaged $50136.1 across 5 years, with a median of $5000.0 in 2022.
  • Biggest five-year swings in Revenue: soared 3089.99% in 2021 and later tumbled 98.02% in 2022.
  • Year by year, Revenue stood at $252855.0 in 2021, then crashed by 98.02% to $5000.0 in 2022, then changed by 0.0% to $5000.0 in 2023, then changed by 0.0% to $5000.0 in 2024, then changed by 0.0% to $5000.0 in 2025.
  • Business Quant data shows Revenue for SKVI at $5000.0 in Q4 2025, $5000.0 in Q3 2025, and $5000.0 in Q2 2025.